A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells

Dendritic cell (DC)-based vaccines are recognized as a promising immunotherapeutic strategy against cancer. Various adjuvants are often incorporated to enhance the modest immunogenicity of DC vaccines. More specifically, many of the commonly used adjuvants are derived from bacteria. In the current s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Kim, Young Seob, Park, Hyun Jin, Park, Jung Hwa, Hong, Eun Ji, Jang, Gun-Young, Jung, In Duk, Han, Hee Dong, Lee, Seung-Hyun, Vo, Manh-Cuong, Lee, Je-Jung, Yang, Andrew, Farmer, Emily, Wu, T.-C., Kang, Tae Heung, Park, Yeong-Min
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6169573/
https://ncbi.nlm.nih.gov/pubmed/30288341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1472187
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars